MyAverix Finance
SHG · Healthcare
Harbin Pharmaceutical Group Co Ltd (600664)
Drug Manufacturers - Specialty & Generic
Harbin Pharmaceutical Group Co Ltd (600664) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600664
Harbin Pharmaceutical Group Co Ltd (600664) — FAQ
What is 600664's P/E ratio?
The price-to-earnings (P/E) ratio for Harbin Pharmaceutical Group Co Ltd (600664) is 18.00 (data as of 2026-03-23).
Does Harbin Pharmaceutical Group Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Harbin Pharmaceutical Group Co Ltd (600664). Check the MyAverix Finance app for the latest dividend data.
What sector is Harbin Pharmaceutical Group Co Ltd in?
Harbin Pharmaceutical Group Co Ltd (600664) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600664 listed on?
600664 is listed on SHG.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.